The main goals are steady metabolism, stable appetite, and ongoing support, not fast weight loss
CrossRef Geospatial patterns and socioeconomic determinants of the global acute viral hepatitis burden Ke-Jie He, Guoyu Gong Frontiers in Public Health .2025;[Epub] CrossRef Reevaluating antiviral thresholds in HBV DNA-negative inactive HBsAg carriers: a multicenter histopathological analysis Shan Ren, Sujun Zheng, Xinyang Zhang, Junliang Fu, Rongshan Fan, Qingfa Ruan, Wenqi Huang, Haibing Gao, Xiulan Xue, Fang Yang, Yao Xie, Minghui Li, Xinyue Chen Virology Journal .2025;[Epub] CrossRef Evaluating Non-Invasive Biomarkers and Composite Scores for Liver Fibrosis Diagnosis in Hepatitis B and C Infections Tamer A
Maurer AD, Eller LK, Hallam MC, Taylor K, Reimer RA
Another oral GLP-1 drug, orforglipron (Foundayo) has just been approved by the FDA for weight management